TetraScience and Thermo Fisher Scientific Partner to Accelerate Scientific AI Across Biopharma R&D and Manufacturing

 TetraScience, the Scientific Data and AI company,  announced a collaboration with Thermo Fisher Scientific Inc., the world leader in serving s...

January 13, 2026 | Tuesday | News
Charles River to Acquire K.F. Cambodia and PathoQuest, Strengthening DSA Supply Chain and Expanding NAMs Capabilities

Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnin...

January 13, 2026 | Tuesday | News
Alnylam CEO Yvonne Greenstreet Outlines Five-Year Strategy as Company Reports Strong 2025 Growth and 2026 Outlook

− Full Year 2025 Preliminary* Net Product Revenues of $2,987 Million (81% Growth vs. 2024), Driven Primarily by Preliminary* Total TTR Revenues o...

January 13, 2026 | Tuesday | Company results
Enginzyme and AGC Present Scalable Manufacturing Process for Key mRNA Ingredient m¹ΨTP

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-met...

January 13, 2026 | Tuesday | News
QIAGEN CEO Thierry Bernard Outlines 2026 Growth Priorities to Accelerate Path to $2 Billion in Pillar Sales by 2028

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined...

January 13, 2026 | Tuesday | Company results
Lilly Bets on Chronic Inflammation With $1.2B All-Cash Acquisition of Ventyx

Eli Lilly and Company (NYSE: LLY) and Ventyx Biosciences, Inc. (Nasdaq: VTYX), a San Diego-based clinical-stage biopharmaceutical company focused on...

January 11, 2026 | Sunday | News
Etienna Bio Secures Exclusive Global License From UMass Chan for Adipose-Derived Cell and Matrix Platform

Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled biomaterials for regenerative and aesthetic application...

January 12, 2026 | Monday | News
Revvity and Eli Lilly Expand AI Drug Discovery Collaboration via Signals Xynthetica

Revvity, Inc. announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by ma...

January 12, 2026 | Monday | News
Codexis and Axolabs Partner to Evaluate Enzymatic RNA Manufacturing Platform

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Gr...

January 12, 2026 | Monday | News
Shilpa Medicare’s OERIS™ Clears Phase 3, Showing Superior Convenience, Efficacy and Safety in CINV

Phase 3 study met all primary and secondary endpoints, demonstrating superior convenience, strong efficacy, and excellent safety versus conventional ondans...

January 12, 2026 | Monday | News
Charles River Laboratories Charts A Deliberate Leadership Transition To Power Its Next Phase Of Growth

Charles River Laboratories’ announcement of a planned leadership transition marks one of the most consequential succession moments in the global pr...

January 09, 2026 | Friday | News
Early Prescriber Confidence Is Clear,” Says LENZ Therapeutics CEO Eef Schimmelpennink as VIZZ Launch Exceeds Expectations

Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in mid-...

January 09, 2026 | Friday | Company results
Sharp Sterile Advances Global Growth Strategy With $28M Lee Facility Expansion

Sharp Sterile Manufacturing has  announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will st...

January 09, 2026 | Friday | News
HealthBiome Secures Dual U.S. FDA and Korean MFDS Approvals for Akkermansia Postbiotic with Muscle Health Claim

Akkermansia muciniphila postbiotic receives both U.S. FDA dietary supplement clearance and Korean functional ingredient approval with muscle health ...

January 08, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close